Join

Compare · MDLN vs NYXH

MDLN vs NYXH

Side-by-side comparison of Medline Inc. (MDLN) and Nyxoah SA (NYXH): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both MDLN and NYXH operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
  • MDLN is the larger of the two at $46.86B, about 285.5x NYXH ($164.1M).
  • Over the past year, MDLN is down 12.5% and NYXH is down 74.6% - MDLN leads by 62.0 points.
  • MDLN has been more active in the news (12 items in the past 4 weeks vs 4 for NYXH).
  • MDLN has more recent analyst coverage (25 ratings vs 9 for NYXH).
PerformanceMDLN-12.54%NYXH-65.90%
2025-12-17+0.00%2026-08-25
MetricMDLNNYXH
Company
Medline Inc.
Nyxoah SA
Price
$35.64+2.77%
$1.63+1.24%
Market cap
$46.86B
$164.1M
1M return
-10.28%
+15.60%
1Y return
-12.54%
-74.57%
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Exchange
NASDAQ
NASDAQ
IPO
2025
2021
News (4w)
12
4
Recent ratings
25
9
NYXH

Nyxoah SA

Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium.